Tags:DevelopmentDrugMedTechProductTechnology
Evgen Pharma is a clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases
Location: United Kingdom, England, Wilmslow
Member count: 1-10
Total raised: $3.801041M
Founded date: 2007

Investors 1

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
09.09.2015-$3.088459M--
25.07.2012-$712.582KThe North ...finsmes.co...

Mentions in press and media 5

DateTitleDescriptionCategoryAuthorSource
14.03.2023OKYO Pharm...---globenewsw...
11.10.2022STALICLA s... STALICLA's unique approach a...Success-startuptic...
26.04.2021EVGEN PHAR...Evgen (AIM: EVG), a clinical s...--marketscre...
25.07.2012Evgen Rais...Evgen, a Liverpool, UK-based c...funding S...-finsmes.co...
20.09.2011Evgen Rais...Evgen Limited, a Liverpool, UK...funding S...-finsmes.co...